You are here

Found 32 results

Sort by:[Year][Author]
Filters: keyword is Humans  [Clear All Filters]
2007
Ortega RoldanJL, Romero RomeroML, OraA, AbE, LopezMayorga O, AzuagaAI, van NulandNA.  2007.  The high resolution NMR structure of the third SH3 domain of CD2AP. 39(4):331-336. Abstract
AdriaensenC, De GreveH, TianJQ, De CraeyeS, GubbelsE, EeckhautV, Van ImmerseelF, DucatelleR, KumarM, HernalsteensJP.  2007.  A live Salmonella enterica serovar Enteritidis vaccine allows serological differentiation between vaccinated and infected animals. 75(5):2461-2468. Abstract
De GreveH, WynsL, BouckaertJ.  2007.  Combining sites of bacterial fimbriae. Current opinion in structural biology. 17(5):506-512. Abstract
2005
TielkerD, HackerS, LorisR, StrathmannM, WingenderJ, WilhelmS, RosenauF, JaegerKE.  2005.  Pseudomonas aeruginosa lectin LecB is located in the outer membrane and is involved in biofilm formation. 151(Pt 5):1313-1323. Abstract
DumoulinM, CanetD, LastAM, PardonE, ArcherDB, MuyldermansS, WynsL, MatagneA, RobinsonCV, RedfieldC, DobsonCM.  2005.  Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations. Nature. 346(3):773-788. Abstract
BouckaertJ, BerglundJ, SchembriM, De Genst E, CoolsL, WuhrerM, HungCS, PinknerJ, SlattegardR, ZavialovA, ChoudhuryD, LangermannS, HultgrenSJ, WynsL, KlemmP, OscarsonS, KnightSD, De Greve H.  2005.  Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin. Molecular Microbiology. 55(2):441-455. Abstract
2004
TzakosAG, FuchsP, van NulandNA, TroganisA, TseliosT, DeraosS, MatsoukasJ, GerothanassisIP, BonvinAM.  2004.  NMR and molecular dynamics studies of an autoimmune myelin basic protein peptide and its antagonist: structural implications for the MHC II (I-Au)-peptide complex from docking calculations. 271(16):3399-3413. Abstract
WallJS, GuptaV, WilkersonM, SchellM, LorisR, AdamsP, SolomonA, StevensF, DealwisC.  2004.  Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vlambda6 proteins. 17(4):323-331. Abstract
HechtO, van NulandNA, SchleinkoferK, DingleyAJ, BruhnH, LeippeM, GrotzingerJ.  2004.  Solution structure of the pore-forming protein of Entamoeba histolytica. 279(17):17834-17841. Abstract
2003
DumoulinM, LastAM, DesmyterA, DecanniereK, CanetD, LarssonG, SpencerA, ArcherDB, SasseJ, MuyldermansS, WynsL, RedfieldC, MatagneA, RobinsonCV, DobsonCM.  2003.  A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme. 424(6950):783-788. Abstract
LoverixS, SteyaertJ.  2003.  Ribonucleases: from prototypes to therapeutic targets?. Current Medicinal Chemistry. 10(9):779-785. Abstract
2002
De GreveH, QizhiC, DeboeckF, HernalsteensJP.  2002.  The Shiga-toxin VT2-encoding bacteriophage phi297 integrates at a distinct position in the Escherichia coli genome. 1579(2-3):196-202. Abstract
LorisR.  2002.  Principles of structures of animal and plant lectins. 1572(2-3):198-208. Abstract
DumoulinM, ConrathK, VanMeirhaeghe A, MeersmanF, HeremansK, FrenkenLG, MuyldermansS, WynsL, MatagneA.  2002.  Single-domain antibody fragments with high conformational stability. 11(3):500-515. Abstract
2001
DesmyterA, DecanniereK, MuyldermansS, WynsL.  2001.  Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody. 276(28):26285-26290. Abstract
MuyldermansS, CambillauC, WynsL.  2001.  Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains. 26(4):230-235. Abstract
TibazarwaC, CorbisierP, MenchM, BossusA, SoldaP, MergeayM, WynsL, van derLelie D.  2001.  A microbial biosensor to predict bioavailable nickel in soil and its transfer to plants. 113(1):19-26. Abstract
2000
FernandezAM, VillegasV, MartinezJC, van NulandNA, Conejero-LaraF, AvilesFX, SerranoL, FilimonovVV, MateoPL.  2000.  Thermodynamic analysis of helix-engineered forms of the activation domain of human procarboxypeptidase A2. 267(19):5891-5899. Abstract
DecanniereK, MuyldermansS, WynsL.  2000.  Canonical antigen-binding loop structures in immunoglobulins: more structures, more canonical classes?. 300(1):83-91. Abstract
1999
ChitiF, TaddeiN, GiannoniE, van NulandNA, RamponiG, DobsonCM.  1999.  Development of enzymatic activity during protein folding. Detection of a spectroscopically silent native-like intermediate of muscle acylphosphatase. 274(29):20151-20158. Abstract
NguyenVK, HamersR, WynsL, MuyldermansS.  1999.  Loss of splice consensus signal is responsible for the removal of the entire C(H)1 domain of the functional camel IGG2A heavy-chain antibodies. 36(8):515-524. Abstract
DecanniereK, DesmyterA, LauwereysM, GhahroudiMA, MuyldermansS, WynsL.  1999.  A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops. 7(4):361-370. Abstract
1998
ChitiF, TaddeiN, van NulandNA, MagheriniF, StefaniM, RamponiG, DobsonCM.  1998.  Structural characterization of the transition state for folding of muscle acylphosphatase. 283(4):893-903. Abstract
van NulandNA, ChitiF, TaddeiN, RaugeiG, RamponiG, DobsonCM.  1998.  Slow folding of muscle acylphosphatase in the absence of intermediates. 283(4):883-891. Abstract
LauwereysM, ArbabiGhahroudi M, DesmyterA, KinneJ, HolzerW, DeGenst E, WynsL, MuyldermansS.  1998.  Potent enzyme inhibitors derived from dromedary heavy-chain antibodies. 17(13):3512-3520. Abstract

Publications on

Most recent publications